Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation

doi:10.4330/wjc.v14.i10.537

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3513)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

172

WORD

HTML

1471

Figures (1-2)

184

Tables (1-2)

175

Sum=2049

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

197

Download

505

Sum=702

Publishing Process of This Article

Item

Count

Browse

245

Download

517

Sum=762

Oct 26, 2022 (publication date) through Oct 6, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Cardiol. Oct 26, 2022; 14(10): 537-545
Published online Oct 26, 2022. doi: 10.4330/wjc.v14.i10.537

Table 2 Multivariate adjusted Cox-proportional hazard model of atrial arrhythmia recurrence after cryoablation by angiotensin converting enzyme inhibitors/angiotensin receptor blockers

Outcome of interest	ACEI/ARB HR (95%CI)	No ACEI/ARB HR (95%CI)	P value
Recurrence of AA		Ref
Model 1^a	1.78 (0.72, 4.42)	1.00	0.66
Model 2^b	1.37 (0.51, 3.72)	1.00	0.72

^aModel 1 adjusted for age and sex.

^bModel 2 adjusted for model 1 + coronary artery disease, congestive heart failure, diabetes mellitus, hypertension and valvular heart disease.

AA: Atrial arrhythmia; ACE-I: Angiotensin converting enzyme inhibitors; ARB: Angiotensin receptor blockers; HR: Hazard ratio; CI: Confidence interval.

Citation: Al-Seykal I, Bose A, Chevli PA, Hashmath Z, Sharma N, Mishra AK, Laidlaw D. Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation. World J Cardiol 2022; 14(10): 537-545
URL: https://www.wjgnet.com/1949-8462/full/v14/i10/537.htm
DOI: https://dx.doi.org/10.4330/wjc.v14.i10.537